Distinct placental molecular processes associated with early-onset and late-onset preeclampsia

• Published in: Theranostics Vol. 11; no. 10; pp. 5028 - 5044
• Main Authors: Ren, Zhonglu, Gao, Yunfei, Gao, Yue, Liang, Guanmei, Chen, Qian, Jiang, Sijia, Yang, Xiaoxue, Fan, Cuixia, Wang, Haizhen, Wang, Jing, Shi, Yi-Wu, Xiao, Chaoqun, Zhong, Mei, Yang, Xinping
• Format: Journal Article
• Language: English
• Published: Australia Ivyspring International Publisher Pty Ltd 01.01.2021; Ivyspring International Publisher
• Subjects: Blood pressure; Classification; Gene expression; Genomes; Gestational age; Hypertension; Pathogenesis; Placenta; Preeclampsia; Principal components analysis; Research Paper; clinical subtypes; placenta; molecular mechanism; preeclampsia; transcriptome
• ISSN: 1838-7640; 1838-7640
• DOI: 10.7150/thno.56141

Patients with preeclampsia display a spectrum of onset time and severity of clinical presentation, yet the underlying molecular bases for the early-onset and late-onset clinical subtypes are not known. Although several transcriptome studies have been done on placentae from PE patients, only a small number of differentially expressed genes have been identified due to very small sample sizes and no distinguishing of clinical subtypes. We carried out RNA-seq on 65 high-quality placenta samples, including 33 from 30 patients and 32 from 30 control subjects, to search for dysregulated genes and the molecular network and pathways they are involved in. We identified two functionally distinct sets of dysregulated genes in the two major subtypes: 2,977 differentially expressed genes in early-onset severe preeclampsia, which are enriched with metabolism-related pathways, notably transporter functions; and 375 differentially expressed genes in late-onset severe preeclampsia, which are enriched with immune-related pathways. We also identified some key transcription factors, which may drive the widespread gene dysregulation in both early-onset and late-onset patients. These results suggest that early-onset and late-onset severe preeclampsia have different molecular mechanisms, whereas the late-onset mild preeclampsia may have no placenta-specific causal factors. A few regulators may be the key drivers of the dysregulated molecular pathways.